Top Markets
Coin of the day
Poniard Pharmaceuticals, Inc. Poniard Pharmaceuticals, Inc.

Poniard Pharmaceuticals, Inc.

PARD
Kedudukan dalam Saham #42765
Poniard Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to the... Poniard Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to the discovery and market introduction of cancer treatments. Its flagship product candidate, Picoplatin, is a platinum-based therapy targeting various cancer types, such as small cell lung, colorectal, prostate, and ovarian cancers. The company has advanced Picoplatin through several clinical stages, including a pivotal Phase III SPEAR trial for small cell lung cancer patients in a second-line treatment setting. Furthermore, Phase II studies investigated Picoplatin as an initial therapy for metastatic colorectal cancer and hormone-refractory prostate cancer. An early-stage Phase I trial also examined an oral formulation of Picoplatin for solid tumors. Founded in 1984 as NeoRx Corporation, the company rebranded to Poniard Pharmaceuticals, Inc. in September 2006 and operates from its base in Seattle, Washington.
Harga Saham
$0.0001
Disegerakkan terakhir: 2026-08-11
Modal Pasaran
$150.00
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan Poniard Pharmaceuticals, Inc. (PARD)

Kategori

Harga PARD dengan permodalan pasaran b
Poniard Pharmaceuticals, Inc. Poniard Pharmaceuticals, Inc.
PARD
$0.0001
Modal pasaran bagi Poniard Pharmaceuticals, Inc.(PARD)
Modal Pasaran: $150.00
Sehingga August 2026, Poniard Pharmaceuticals, Inc. mempunyai modal pasaran sebanyak $150.00. Ini menjadikan Poniard Pharmaceuticals, Inc. syarikat ke-42765th paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran Poniard Pharmaceuticals, Inc. dari 1988 hingga 2026
PARD berbanding dengan 5 teratas yang paling popular stocks
Harga PARD Aset B Pasaran B Hasilnya
Poniard Pharmaceuticals, Inc. Poniard Pharmaceuticals, Inc.
$3,617,326 $150.00
$5.426T +3,617,325,682,222.00%
Poniard Pharmaceuticals, Inc. Poniard Pharmaceuticals, Inc.
$2,951,277 $150.00
$4.427T +2,951,277,314,540.00%
Poniard Pharmaceuticals, Inc. Poniard Pharmaceuticals, Inc.
$2,759,300 $150.00
$4.139T +2,759,299,687,403.33%
Poniard Pharmaceuticals, Inc. Poniard Pharmaceuticals, Inc.
$2,437,362 $150.00
$3.656T +2,437,362,459,384.67%
Poniard Pharmaceuticals, Inc. Poniard Pharmaceuticals, Inc.
$1,923,764 $150.00
$2.886T +1,923,763,906,900.00%